Abstract:The application of metabolomics in translational research suffers from several technological bottlenecks, such as data reproducibility issues and the lack of standardization of sample profiling procedures. Here, we report an automated high-throughput metabolite array technology that can rapidly and quantitatively determine 324 metabolites including fatty acids, amino acids, organic acids, carbohydrates, and bile acids. Metabolite identification and quantification is achieved using the Targeted Metabolome Batch Quantification (TMBQ) software, the first cross-vendor data processing pipeline. A test of this metabolite array was performed by analyzing serum samples from patients with chronic liver disease (<i>N</i> = 1234). With high detection efficiency and sensitivity in serum, urine, feces, cell lysates, and liver tissue samples and suitable for different mass spectrometry systems, this metabolite array technology holds great potential for biomarker discovery and high throughput clinical testing. Additionally, data generated from such standardized procedures can be used to generate a clinical metabolomics database suitable for precision medicine in next-generation healthcare.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.analchem.0c04686?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.analchem.0c04686</a>.MRM transitions of 3-NPH derivatized metabolites, linearity range, precision, and accuracy (Table S1) (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c04686/suppl_file/ac0c04686_si_001.xlsx">XLSX</a>)UPLC-MS/MS instrument settings (Table S2). Clinical information on study subjects (Table S3). Stability of derivatized analytes in biological sample matrices stored under −80 °C (Table S4). Metabolites identified by TargetLynx (Table S5). Metabolites identified by TMBQ (Table S6). The relative differences of levels of metabolites (mean ± S.D.) identified by TMBQ and TargetLynx (Table S7). The Pearson correlation coefficients of the same metabolites quantified by TMBQ and TargetLynx (Table S8). Quantification results in normal human serum, urine, feces, mouse liver and HepG2 cell samples (Median ± SE) (Table S9). Detected metabolites in the control and liver disease patients (Table S10). Effect of the concentration and quantity of the 3-nitrophenylhydrazine on the chemical derivatization (Figure S1). Effect of the concentration and quantity of the EDC on the 3-nitrophenylhydrazine derivatization (Figure S2). Effect of reaction temperature on the 3-nitrophenylhydrazine derivatization of some selected metabolites (Figure S3). Effect of reaction time on the 3-nitrophenylhydrazine derivatization of some selected metabolites (Figure S4). Typical TIC chromatograms of all 320 metabolite standards (Figure S5). Typical EIC of organic acid standards (Figure S6). Typical EIC of carbohydrates (Figure S7). Typical EIC of bile acid standards (Figure S8). Typical EIC of fatty acid standards (Figure S9). Typical EIC of amino acids and nucleotides (Figure S10). Typical EIC of short chain fatty acids (Figure S11). Workflow and main features of TMBQ (Figure S12). Fragmentation pattern of butyric acid in ESI negative mode as an example (Figure S13). The real metabolite assay kit of the metabolite array used for the analysis of samples in this study (Figure S14). OPLS-DA scores plots of serum metabolite profiles of the controls and liver disease patients and Pie chart showing the chemical classification of the detected metabolites in liver disease patients (Figure S15). 3D scores plot of serum metabolite profiles of (A) HBV patients, fibrosis and cirrhosis patients, and (B) HCC and ICC patients (Figure S16) (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c04686/suppl_file/ac0c04686_si_002.pdf">PDF</a>)This article has not yet been cited by other publications.

Serially Coupled Reversed Phase-Hydrophilic Interaction Liquid Chromatography–tailored Multiple Reaction Monitoring, a Fit-for-purpose Tool for Large-Scale Targeted Metabolomics of Medicinal Bile

Advanced Liquid Chromatography-Mass Spectrometry Enables Merging Widely Targeted Metabolomics and Proteomics.

High Throughput and Quantitative Measurement of Microbial Metabolome by Gas Chromatography/Mass Spectrometry Using Automated Alkyl Chloroformate Derivatization.

A Metabolite Array Technology for Precision Medicine

Expanding the Scope of Targeted Metabolomics by One-pot Microscale Synthesis and Tailored Metabolite Profiling: Investigation of Bile Acid-Amino Acid Conjugates.

Liquid Chromatography-Mass Spectrometric Multiple Reaction Monitoring-Based Strategies For Expanding Targeted Profiling Towards Quantitative Metabolomics

A Chemical Derivatization-Based Pseudotargeted Liquid Chromatography-Tandem Mass Spectrometry Method for Sensitive and High Coverage Determination of Bile Acids in Human Serum

Liquid Chromatography-Mass Spectrometric Multiple Reaction Monitoring-Based Strategies for Expanding Targeted Profiling Towards Quantitative Metabolomics.

Development of Simultaneous Targeted Metabolite Quantification and Untargeted Metabolomics Strategy Using Dual-Column Liquid Chromatography Coupled with Tandem Mass Spectrometry

Stepwise solid phase extraction integrated with chemical derivatization for all-in-one injection LC-MS/MS analysis of metabolome and lipidome

Polarity-extended liquid chromatography-triple quadrupole mass spectrometry for simultaneous hydrophilic and hydrophobic metabolite analysis

Comprehensive Analysis of Bile Medicines Based on UHPLC-QTOF-MSE and Machine Learning

Potential of hyphenated ultra-high performance liquid chromatography-scheduled multiple reaction monitoring algorithm for large-scale quantitative analysis of traditional Chinese medicines

Metabolite profiling and characterization for medicinal herbal remedies.

A merged method for targeted analysis of amino acids and derivatives using parallel reaction monitoring combined with untargeted profiling by HILIC-Q-Orbitrap HRMS

Polarity-extended Quantitative Analysis of Bear Bile and Its Analogues Using Serially Coupled Reversed Phase-Hydrophilic Interaction Liquid Chromatography-Tailored Multiple Reaction Monitoring

Quantification of Bile Acids in Traditional Animal Medicines and Their Preparations Using Ultra High-Performance Liquid Chromatography-Mass Spectrometry in the Multiple Reaction Monitoring Mode

Strategies for Large-Scale Targeted Metabolomics Quantification by Liquid Chromatography-Mass Spectrometry

Rapid analysis of bile acids in different biological matrices using LC-ESI-MS/MS for the investigation of bile acid transformation by mammalian gut bacteria

Sensitive profiling of phenols, bile acids, sterols, and eicosanoids in mammalian urine by large volume direct injection-online solid phase extraction-ultra high performance liquid chromatography-polarity switching tandem mass spectrometry

An integrated strategy combining metabolomics and machine learning for the evaluation of bioactive markers that differentiate various bile